Evidence map›Paper›PMID 28139975›Full record

ArticleeLife2017

Operon mRNAs are organized into ORF-centric structures that predict translation efficiency.

David H Burkhardt, Silvi Rouskin, Yan Zhang, Gene-Wei Li, Jonathan S Weissman, Carol A Gross

Abstract read
In one paragraph

Article in eLife, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed.

  1. Collided ribosomes are rescued by the endonuclease Rae1 andbioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. RNA Structure Coordinates Translation Across the Meiotic Program.bioRxiv : the preprint server for biology · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Temperature-Dependent tRNA Modifications in Bacillales.International journal of molecular sciences · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Research progress in mRNA drug modification and delivery systems.Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2023
    Review

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

David H BurkhardtGraduate Group in Biophysics, University of California, San Francisco, San Francisco, United States.
Silvi RouskinCalifornia Institute of Quantitative Biology, University of California, San Francisco, San Francisco, United States.
Yan ZhangDepartment of Microbiology and Immunology, University of California, San Francisco, San Francisco, United States.ORCID 0000-0001-5440-1414
Gene-Wei LiCalifornia Institute of Quantitative Biology, University of California, San Francisco, San Francisco, United States.
Jonathan S WeissmanCalifornia Institute of Quantitative Biology, University of California, San Francisco, San Francisco, United States.ORCID 0000-0003-2445-670X
Carol A GrossDepartment of Microbiology and Immunology, University of California, San Francisco, San Francisco, United States.ORCID 0000-0002-5595-9732

Funding

STRUCTURAL BIOLOGY TRAINING PROGRAMT32GM008284 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KORTEMME, TANJA · 1988 to 2022
$10.1M
Cellular homeostasis pathways in bacteriaR35GM118061 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GROSS, CAROL ANNE · 2016 to 2025
$9.0M
MUTATIONAL ANALYSIS OF E COLI CORE RNA POLYMERASER01GM057755 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GROSS, CAROL ANNE · 1998 to 2013
$6.2M
REGULATION OF THE HEAT-SHOCK RESPONSE IN E COLIR01GM036278 · NIGMS · UNIVERSITY OF WISCONSIN MADISON · PI GROSS, CAROL ANNE · 1986 to 2016
$5.2M
Integrative Program in Complex Biological System (ipCBS)T32EB009383 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARSHALL, WALLACE, WEINER, ORION D · 2009 to 2022
$3.2M
Probing the function of translational pausing in bacterial protein synthesisR00GM105913 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LI, GENE-WEI · 2015 to 2017
$747k
Probing the function of translational pausing in bacterial protein synthesisK99GM105913 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LI, GENE-WEI · 2013 to 2014
$180k
Howard Hughes Medical InstituteNIBIB NIH HHS T32 EB009383NIGMS NIH HHS K99 GM105913NIGMS NIH HHS R01 GM036278NIGMS NIH HHS R01 GM057755NIGMS NIH HHS T32 GM008284
6 · The paper itself

Abstract

Bacterial mRNAs are organized into operons consisting of discrete open reading frames (ORFs) in a single polycistronic mRNA. Individual ORFs on the mRNA are differentially translated, with rates varying as much as 100-fold. The signals controlling differential translation are poorly understood. Our genome-wide mRNA secondary structure analysis indicated that operonic mRNAs are comprised of ORF-wide units of secondary structure that vary across ORF boundaries such that adjacent ORFs on the same mRNA molecule are structurally distinct. ORF translation rate is strongly correlated with its mRNA structure in vivo, and correlation persists, albeit in a reduced form, with its structure when translation is inhibited and with that of in vitro refolded mRNA. These data suggest that intrinsic ORF mRNA structure encodes a rough blueprint for translation efficiency. This structure is then amplified by translation, in a self-reinforcing loop, to provide the structure that ultimately specifies the translation of each ORF.

Indexed as

Gene OrderOpen Reading FramesOperonProtein BiosynthesisTranscription, GeneticEscherichia coliGene ExpressionNucleic Acid ConformationRNA, BacterialRNA, MessengerRNA, BacterialRNA, Messengercodon usagecomputational biologyDMS-seqE. coliinfectious diseasemicrobiologymRNA secondary structureribosome profilingsystems biologytranslation efficiency

Identifiers

PMID28139975
PMCPMC5318159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.